VEGFA and skin cancer: For example, impaired tumor vascularization of skin cancer xenografts, as determined by altered blood vessel morphology and decreased expression of proangiogenic factors (VEGF, placental growth factor (PlGF), angiopoietin-2), has been shown in nude mice treated with the CB2 receptor agonist JWH-133 [37].